Log In

Term Description

Quantitative titer results for SARS Coronavirus 2 (SARS-CoV-2) virus IgA antibodies in serum or plasma by an immunofluorescent method, such as Indirect fluorescent antibody testing (IFAT) or Micro Immunofluoresence (MIF). This test may be used in conjunction with SARS-CoV-2 IgM and IgG to aid in the diagnosis of COVID-19 and in the identification of individuals infected with SARS-CoV-2.

Part Description

LP417540-4   SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

LOINC Names Get Info

Fully-Specified Name
SARS coronavirus 2 Ab.IgA:Titr:Pt:Ser/Plas:SemiQn:IF
Long Common Name
SARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence
Short Name
SARS-CoV-2 IgA Titr SerPl IF
Display Name
SARS-CoV-2 (COVID-19) IgA IF [Titer]
Consumer Name Alpha Get Info
SARS-CoV-2 (COVID-19) IgA antibody, Blood

Part Model Get Info

  • Component
    SARS coronavirus 2 Ab.IgA
    LP418430-7
    • Analyte
      SARS coronavirus 2 Ab.IgA
      LP418430-7
      • Component Numerator
        SARS coronavirus 2 Ab.IgA
        LP418430-7
        • Component Numerator Core
          SARS coronavirus 2
          LP417540-4
        • Component Numerator Core Suffix
          Ab.IgA
          LP32398-7
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    Titr
    LP6881-9
  • Time
    Pt
    LP6960-1
  • System
    Ser/Plas
    LP7576-4
    • System Core
      Ser/Plas
      LP7576-4
    • Super System
      NULL
       
  • Scale
    SemiQn
    LP436123-6
  • Method
    IF
    LP6323-2

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.69
Last Updated
Version 2.75 (MAJ)
Order vs. Observation
Both

Member of these Groups Get Info

LOINC GroupGroup Name
LG51018-6SARSCoV2 antibody detection

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)SARS-CoV-2 (COVID-19) IgA:Arbitrární koncentrace (titr):Časový bod:Sérum/plazma:Semikvantitativní:Imunofluoresecence (IF)
de-DEGerman (Germany)SARS-Coronavirus 2 Ak.IgA:Titer:Zeitpunkt:Serum oder Plasma:Semiquantitativ:Immunfluoreszenztest
el-GRGreek (Greece)Κορωνοϊός SARS 2 Αντισώματα IgA:Titr:Pt:Ορός/Πλάσμα:Ημιποσοτική:Ανοσοφθορισμός
Synonyms: MICRO Pt Titr Ανοσοσφαιρίνη Α Ανοσοφθορισμός Αντίσωμα Αντισώματα IgA Ημιποσοτική Κορωνοϊός Κορωνοϊός SARS Κορωνοϊός SARS 2 Ορός Ορός/Πλάσμα Πλάσμα
es-ESSpanish (Spain)Panel del SARS-CoV-2 (COVID-19) IgA:Titulo / Factor de dilución:Punto temporal:Suero o Plasma:Semicuantitativo:Inmunofluorescencia (IF)
Synonyms: Semicuantitativo
es-MXSpanish (Mexico)SARS coronavirus 2 Ab.IgA:Título:Punto temporal:Suero o Plasma:Cuantitativo:Inmunofluorescencia (IF)
fr-CAFrench (Canada)coronavirus 2 du SRAS, IgA:Titre:Temps ponctuel:Sérum/Plasma:SemiQn:Immunofluorescence
fr-FRFrench (France)Coronavirus SARS-CoV-2 Ac IgA:Titre:Ponctuel:Sérum/Plasma:Semi-Quantitatif:Immunofluorescence
it-ITItalian (Italy)SARS coronavirus 2 Ab.IgA:Titr:Pt:Siero/Plasma:SemiQn:IF
Synonyms: anticorpi anti-IgA anticorpo Coronavirus della SARS Immunofluorescenza (IF) Microbiologia Plasma Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Siero Siero o Plasma Titolo
nl-NLDutch (Netherlands)SARS-CoV-2 As.IgA:titer:moment:serum of plasma:semikwantitatief:immunofluorescentie
Synonyms: antistof; antilichaam IF SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
pl-PLPolish (Poland)SARS-CoV-2 Ab.IgA:miano:punkt w czasie:surowica lub osocze:półilościowy:immunofluorescencja
Synonyms: Immunoglobulina A Koronawirus Przeciwciała do SARS-CoV-2;przeciwciała do koronawirusa ciężkiego ostrego zespołu oddechowego typu 2 Przeciwciała IgA do SARS-CoV-2;przeciwciała IgA do koronawirusa ciężkiego ostrego zespołu oddechowego
zh-CNChinese (China)SARS 冠状病毒 2 抗体.IgA:滴定度:时间点:血清/血浆:半定量型:免疫荧光法
Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ Ab.IgA;IgA;抗体 IgA Ab;自身抗体 IFA法;IF法;抗补体免疫荧光法;时间分辨荧光法;荧光原位杂交技术;荧光原位杂交法;荧光抗体 II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒 免疫球蛋白 A 微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体） 效价;滴定浓度;滴定率;滴定量;滴度;稀释倍数;稀释因子;稀释系数 时刻;随机;随意;瞬间 血清或血浆

Example Units

UnitSource
{titer}Example UCUM Units

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=95427-1